Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VHP | Ann: Notice of 2024 Annual Meeting | 05:50 | 0 | 22 | |||
|
|||||||
VHP | Ann: SPH Notice - Forsyth Barr Investment Management Limited | 24/09/24 | 0 | 44 | |||
|
|||||||
VHP | Ann: SPH Notice - Accident Compensation Corporation (ACC) | 23/09/24 | 0 | 45 | |||
|
|||||||
VHP | Ann: D&O ongoing disclosure - Graham Stuart DRP | 20/09/24 | 0 | 62 | |||
|
|||||||
VHP | Ann: D&O ongoing disclosure - Aaron Hockly DRP | 20/09/24 | 0 | 61 | |||
|
|||||||
VHP | Ann: Allotment of distribution reinvestment plan units | 19/09/24 | 0 | 39 | |||
|
|||||||
VHP | Ann: D&O ongoing disclosure - Angela Bull | 17/09/24 | 0 | 46 | |||
|
|||||||
VHP | Ann: DRP strike price set at $1.939971 | 11/09/24 | 0 | 52 | |||
|
See All Discussions